Product Description: JNJ-47965567 is a centrally permeable, high-affinity, selective P2X7 antagonist, with pKis of 7.9 and 8.7 for human and rat P2X7, respectively. JNJ-47965567 can be used to probe the role of central P2X7 in rodent models of CNS pathophysiology[1].
Applications: Neuroscience-Neuromodulation
Formula: C28H32N4O2S
References: [1]Bhattacharya A, et al. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. Br J Pharmacol. 2013 Oct;170(3):624-40.
CAS Number: 1428327-31-4
Molecular Weight: 488.64
Compound Purity: 99.79
Research Area: Neurological Disease
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: P2X Receptor